PMGC Holdings Inc.
Close on Oct 19, 2026
- Market cap
- $13.80M
- P/E (TTM)
- –
- Dividend yield
- –
About PMGC
Pharmaceutical Preparations, SIC 2834
PMGC Holdings Inc. is a diversified holding company that manages and operates a portfolio of four wholly owned operating subsidiaries. Its subsidiary Northstrive Biosciences develops biopharmaceutical and aesthetic medicine candidates, focusing on engineered probiotic therapies designed to preserve muscle mass during weight loss treatment. Subsidiary Pacific Sun Packaging designs and supplies custom-engineered protective packaging solutions, including trays and carriers for delicate computer processors, memory modules, storage drives, and optical transceivers. Subsidiary AGA Precision Systems operates as a specialized computer numerical control machine shop providing high-tolerance milling, turning, and mold manufacturing for complex metals such as titanium and Inconel. PMGC Capital operates as an investment subsidiary engaged in multi-strategy investing and lending.
The company serves aerospace manufacturers, defense contractors, industrial equipment producers, and over 300 commercial electronics customers across North America, including data center operators and original equipment manufacturers. PMGC Holdings maintains its principal executive office in Newport Beach, California, with manufacturing facilities in California.
Summary of the business section of PMGC's latest annual report, written by StockData.
Company profile
Company
- Legal name
- PMGC Holdings Inc.
- Headquarters
- Newport Beach, CA
- Address
- 120 Newport Center Drive 92660
- Phone
- (888) 445-4886
- Website
- pmgcholdings.com
- Employees
- 32, Dec 31, 2025
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- HTL International, LLC, Houston
Stock & identifiers
- Ticker
- ELAB
- Exchange
- Nasdaq
- IPO date
- Nov 22, 2023
- Shares outstanding
- 8M, Aug 14, 2026
- Public float
- $101.00M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-10 reverse, Aug 21, 2026; 1-for-6 reverse, Mar 10, 2026; 1-for-4 reverse, Jan 6, 2026; 1-for-1400 reverse, Mar 28, 2025; 1-for-7 reverse, Mar 10, 2025; 1-for-200 reverse, Nov 27, 2024
- SEC CIK
- 1840563
- CUSIP
- 28622K302
- ISIN
- US28622K3023
- EIN
- 85-1399981
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Graydon Bensler | Chief Executive Officer, Director | 4,019,557 |
| Jeffrey Parry | Director | 3 |
| George Kovalyov | Director | 0 |
| Juliana Daley | Director | 1 |
| Lichti Braeden | Director | 3,336,437 |
Employees
Headcount reported in annual reports
“As of the date of this Annual Report, we have 32 full-time employees and 2 part-time employee.”
Corporate history
Events identified from SEC filings